The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs

The pandemic caused by SARS-CoV-2 is not over yet, despite all the efforts from the scientific community. Vaccination is a crucial weapon to fight this virus; however, we still urge the development of antivirals to reduce the severity and progression of the COVID-19 disease. For that, a deep underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Saramago, Margarida, Costa, Vanessa G., Souza, Caio S., Bárria, Cátia, Domingues, Susana, Viegas, Sandra C., Lousa, Diana, Soares, Cláudio M., Arraiano, Cecília M., Matos, Rute G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880170/
https://www.ncbi.nlm.nih.gov/pubmed/35208797
http://dx.doi.org/10.3390/microorganisms10020342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880170/
https://www.ncbi.nlm.nih.gov/pubmed/35208797
http://dx.doi.org/10.3390/microorganisms10020342

Ejemplares similares